Buyback Spend for IDEXX Laboratories (IDXX)
Buyback Spend for IDEXX Laboratories (IDXX): headline value $1.22B · YoY +45.4%. Annual and quarterly series, chart, and tables are below.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
Currently viewingBuyback SpendSwitch metric
Latest period
$1.22B
YoY change
+45.4%
5Y CAGR
+46.1%
Peak year (2025)
$1.22B
Latest annual
$1.22B
Buyback Spend history chart for IDEXX Laboratories (IDXX) from 1991 to 2025
Buyback Spend history table for IDEXX Laboratories (IDXX) from 1991 to 2025
| Fiscal year | Period ended | Reported | Buyback Spend | YoY |
|---|---|---|---|---|
| 2025 | $1.22B | +45.4% | ||
| 2024 | $837.03M | +1063.8% | ||
| 2023 | $71.92M | -91.2% | ||
| 2022 | $819.71M | +9.8% | ||
| 2021 | $746.78M | +308.5% | ||
| 2020 | $182.81M | -39.4% | ||
| 2019 | $301.66M | -18.3% | ||
| 2018 | $369.32M | +27.1% | ||
| 2017 | $290.64M | -4.4% | ||
| 2016 | $304.09M | -24.4% | ||
| 2015 | $401.98M | -35.0% | ||
| 2014 | $618.16M | +68.1% | ||
| 2013 | $367.76M | +178.0% | ||
| 2012 | $132.27M | -48.2% | ||
| 2011 | $255.50M | +78.6% | ||
| 2010 | $143.09M | +72.2% | ||
| 2009 | $83.10M | -37.2% | ||
| 2008 | $132.34M | +11.8% | ||
| 2007 | $118.39M | +12.0% | ||
| 2006 | $105.71M | -14.6% | ||
| 2005 | $123.77M | -4.2% | ||
| 2004 | $129.19M | +260.7% | ||
| 2003 | $35.82M | +20.1% | ||
| 2002 | $29.83M | +129.7% | ||
| 2001 | $12.99M | -81.5% | ||
| 2000 | $70.26M | +9.4% | ||
| 1999 | $64.20M | — | ||
| 1998 | $0 | — | ||
| 1997 | $0 | — | ||
| 1996 | $0 | — | ||
| 1995 | $0 | — | ||
| 1994 | $0 | — | ||
| 1993 | $0 | — | ||
| 1992 | $0 | — | ||
| 1991 | $0 | — |
Buyback Spend values are taken from IDEXX Laboratories's reported cash flow statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
The 2025 reading of IDEXX Laboratories (IDXX) buyback spend is $1.22B – surged 45.4% year-over-year.
IDEXX Laboratories buyback spend has grown for 2 consecutive years, with a +46.1% compound annual growth rate over 2020–2025 (5 years).
The highest annual buyback spend of $1.22B was reported in 2025. The lowest in the available history was $0 in 1991.
Among 8 Healthcare peers, IDEXX Laboratories (IDXX) ranks 6th; the peer median for buyback spend is $2.75B.
IDEXX Laboratories Buyback Spend by Year
IDEXX Laboratories Buyback Spend 2025: $1.22B
IDEXX Laboratories buyback spend in 2025 was $1.22B, surged 45.4% from 2024. This figure represents the highest annual value in the available history.
IDEXX Laboratories Buyback Spend 2024: $837.03M
IDEXX Laboratories buyback spend in 2024 was $837.03M, surged 1063.8% from 2023.
IDEXX Laboratories Buyback Spend 2023: $71.92M
IDEXX Laboratories buyback spend in 2023 was $71.92M, plunged 91.2% below 2022.
IDEXX Laboratories Buyback Spend 2022: $819.71M
IDEXX Laboratories buyback spend in 2022 was $819.71M, grew 9.8% from 2021.
IDEXX Laboratories Buyback Spend 2021: $746.78M
IDEXX Laboratories buyback spend in 2021 was $746.78M.
See more financial history for IDEXX Laboratories (IDXX).
Sector peers — Buyback Spend
Companies in the same sector as IDEXX Laboratories, ranked by their latest buyback spend.
| Company | Buyback Spend | Sector |
|---|---|---|
| Johnson & Johnson (JNJ) | $5.95B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $5.54B | Healthcare |
| Merck & Co., Inc. (MRK) | $5.08B | Healthcare |
| Eli Lilly and Company (LLY) | $4.11B | Healthcare |
| Novo Nordisk A/S (NVO) | $1.39B | Healthcare |
| AbbVie Inc. (ABBV) | $980.00M | Healthcare |
| AstraZeneca PLC (AZN) | $719.66M | Healthcare |
| Amgen Inc. (AMGN) | $0 | Healthcare |
Frequently asked questions
What is IDEXX Laboratories's buyback spend?
Latest reported buyback spend for IDEXX Laboratories (IDXX) is $1.22B (period ending December 31, 2025).
How has IDEXX Laboratories buyback spend changed year-over-year?
IDEXX Laboratories (IDXX) buyback spend changed +45.4% year-over-year on the latest annual filing.
What is the long-term growth rate of IDEXX Laboratories buyback spend?
IDEXX Laboratories (IDXX) buyback spend compound annual growth rate is +46.1% over the most recent 5 years available.
When did IDEXX Laboratories buyback spend hit its highest annual value?
IDEXX Laboratories buyback spend reached its highest annual value of $1.22B in 2025.
What was IDEXX Laboratories buyback spend in 2024?
IDEXX Laboratories (IDXX) buyback spend in 2024 was $837.03M.
What was IDEXX Laboratories buyback spend in 2025?
IDEXX Laboratories (IDXX) buyback spend in 2025 was $1.22B.
Metrics overview
Pick a metric for charts, filings and peers — each row shows the latest TTM or most-recent-quarter value.
Explore more
IDXX Overview
Company profile, financial tools, and key metrics
IDXX Revenue Counter
Earns $136.47 every second. See per minute, hour, and day.
IDXX Earnings Counter
Earns $33.60 per second net profit. See per minute, hour, and day.
IDXX Economic Scale
Exceeds Aruba's GDP. Compare with world economies.
IDXX What If Invested
What if you had invested $1,000? See historical returns from any date.
IDXX How It Makes Money
Discover visual breakdown of $4.30B in revenue — where it comes from and where it goes.
IDXX Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
IDXX Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
IDXX Daily Price Character
Explosive · 50.9% historical win rate (green days). Streaks & record days.
IDXX Buybacks
2.25% TTM buyback yield. Shareholder yield & SBC comparison.
IDXX Stock Split History
4 splits on record. Dates, ratios, and cumulative multiple.